Purchase Order 75N95020P00523
- Not listed
- This is a firm-fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), to Biocrates Life Sciences AG, an Austrian company that provides metabolomics assay kits and analytical services. The $525,058.55 contract is for Biocrates to perform metabolomic profiling of 3,021 human plasma samples from the Baltimore Longitudinal Study of Aging to examine the metabolic signatures underlying motor and cognitive decline related to...
- This federal contract award, valued at $91,048.68, was issued by the National Institute on Aging (NIA), a civilian agency, to Biocrates Life Sciences AG, an Austrian-based for-profit organization. The contract is for the provision of targeted quantitative metabolomics assays in brain and blood samples from a rat model of cognitive aging and human induced pluripotent stem cell-derived astrocytes, neurons, and microglia. The objective is to explore metabolic changes associated with cognitive...
- This firm fixed-price purchase order contract was awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) to Biocrates Life Sciences AG, doing business as Biocrates, for $293,721.48. Biocrates is a for-profit organization that provides metabolomics assay kits and services for quantitative, mass spectrometry-based metabolomics analysis to support biomedical, nutrition, and environmental health research across federal agencies including NIH, U.S. Department of...
- This is a firm-fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency of the U.S. government, to Biocrates Life Sciences AG, an Austrian company specializing in metabolomics assay kits, laboratory services, and targeted metabolite analysis. The contract, valued at $272,457.10, does not have a set-aside designation, indicating Biocrates competed for this award in an unrestricted manner. The contract involves the supply of Biocrates' products and...
- This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse to Biocrates Life Sciences AG, doing business as Biocrates, for the supply of drugs and biological materials. The $158,650.00 contract does not have a set-aside designation and is for the delivery of metabolomics assay kits, equipment, and services in support of biomedical, nutrition, and environmental health research...
- The U.S. Department of Agriculture awarded a firm fixed-price purchase order to Biocrates Life Sciences AG, an Austrian metabolomics technology company, on August 4, 2020, with a ceiling value of $54,208. The contract calls for the delivery of Biocrates MXP QUANT 500 assay kits, which are advanced metabolomic analysis tools used for precise, mass spectrometry-based quantification of metabolites in biological samples. The solicitation was posted on July 23, 2020, with a due date of July 30, 2020,...
- This is a federal purchase order contract awarded by the Food and Drug Administration (FDA) to Biocrates Life Sciences AG, an Austrian-based company specializing in metabolomics technologies and quantitative laboratory services. The contract is for the provision of Metabolomics Analysis Kits, with a ceiling value of $12,508.50 and a period of performance ending on April 16, 2016. The contract is a firm fixed-price agreement, with no set-aside designation. Biocrates Life Sciences AG is a...
- This firm-fixed-price purchase order was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Eye Institute to Biocrates Life Sciences AG, an Austrian company doing business as Biocrates. The $20,500 contract is for Biocrates to provide ready-to-measure kits and laboratory services for quantitative, reproducible, and standardized mass spectrometry-based metabolomics analysis in support of biomedical, nutrition, and environmental health...
- This is a federal purchase order contract awarded by the National Institute on Aging, a civilian agency, to Biocrates Life Sciences AG, a for-profit Austrian company. The contract is for the delivery of Biocrates' MXP-QUANT 500 XL KITS, which are quantitative metabolomics assay kits. The contract has a firm-fixed-price of $24,265.60 and a period of performance ending on September 25, 2024. The contract does not have a set-aside designation, indicating it was competitively awarded. Biocrates...
- <p>The National Institutes of Health National Institute on Aging, within the Department of Health and Human Services, awarded a $638,000 firm fixed price delivery order contract to QPS Austria GmbH. The contract is for experimental validation of candidate Alzheimer's disease treatments identified through multi-omics analyses. The period of performance is from June 1, 2022 through May 31, 2023, with all work to be conducted in Austria by QPS Austria GmbH as the prime contractor.</p>
The National Institute on Drug Abuse awarded a $45,881.30 firm fixed-price purchase order to Biocrates Life Sciences AG, an Austrian-based metabolomics company, on September 4, 2020, for research supporting the study "Brain and Blood Bile Acid Concentrations in Cognitive Aging and Alzheimer's Disease." The contract was completed by September 29, 2021, and was not subject to any set-aside designation. Biocrates specializes in metabolomics technologies and quantitative laboratory services, providing advanced assay kits and analytical capabilities that enable precise mass spectrometry-based metabolite analysis for research institutions. This award reflects Biocrates' competitive positioning in supplying metabolomic research technologies to federal agencies. The company has established a track record of delivering similar services to civilian agencies including the National Institutes of Health divisions such as the National Institute on Aging and the National Eye Institute, as well as the U.S. Department of Agriculture and the Environmental Protection Agency. The contract supports neuroscience research related to cognitive aging and Alzheimer's disease, aligning with research priorities within the National Institute on Drug Abuse's broader research portfolio. As of the award date, this contract represented one of several federal awards to Biocrates, demonstrating sustained federal demand for their specialized metabolomics capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | ($132) | 9/16/25 | |
| Not listed | Not listed | $46.0k | 9/4/20 |